483 Document: Rentschler Biopharma SE, Feb 15, 2022

FDANews 483 Rentschler Biopharma SE Feb 15 2022 top
Wayne E. Seifert FDA Investigator

On Feb 15, 2022, the FDA inspected Rentschler Biopharma SE's Laupheim site. Explore the inspectional observations.